Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $98.1 million.

  • Zenas BioPharma's Non-cash Items rose 2390.53% to $98.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.1 million, marking a year-over-year increase of 2390.53%. This contributed to the annual value of $74.4 million for FY2024, which is 82033.65% up from last year.
  • Latest data reveals that Zenas BioPharma reported Non-cash Items of $98.1 million as of Q3 2025, which was up 2390.53% from $1.6 million recorded in Q2 2025.
  • Zenas BioPharma's Non-cash Items' 5-year high stood at $98.1 million during Q3 2025, with a 5-year trough of $1.4 million in Q1 2025.
  • In the last 3 years, Zenas BioPharma's Non-cash Items had a median value of $41.2 million in 2023 and averaged $43.8 million.
  • As far as peak fluctuations go, Zenas BioPharma's Non-cash Items soared by 82033.65% in 2024, and later soared by 2390.53% in 2025.
  • Zenas BioPharma's Non-cash Items (Quarter) stood at $8.1 million in 2023, then skyrocketed by 820.34% to $74.4 million in 2024, then soared by 31.9% to $98.1 million in 2025.
  • Its Non-cash Items was $98.1 million in Q3 2025, compared to $1.6 million in Q2 2025 and $1.4 million in Q1 2025.